Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for targeted cancer therapies. Its boronic acid functional group enables participation in Suzuki-Miyaura cross-coupling reactions, allowing efficient formation of carbon-carbon bonds during drug assembly. Commonly employed in medicinal chemistry for constructing biaryl motifs found in bioactive molecules. Also utilized in the preparation of protease inhibitors and anti-inflammatory agents due to its structural compatibility with enzyme active sites. Its cyclopropylmethoxy pyridine core enhances metabolic stability and binding affinity in final drug candidates.